Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kip1 expression
- PMID: 10827191
- DOI: 10.1074/jbc.M003145200
Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kip1 expression
Abstract
The PTEN tumor suppressor gene is frequently inactivated in human prostate cancers, particularly in more advanced cancers, suggesting that the AKT/protein kinase B (PKB) kinase, which is negatively regulated by PTEN, may be involved in human prostate cancer progression. We now show that AKT activation and activity are markedly increased in androgen-independent, prostate-specific antigen-positive prostate cancer cells (LNAI cells) established from xenograft tumors of the androgen-dependent LNCaP cell line. These LNAI cells show increased expression of integrin-linked kinase, which is putatively responsible for AKT activation/Ser-473 phosphorylation, as well as for increased phosphorylation of the AKT _target protein, BAD. Furthermore, expression of the p27(Kip1) cell cycle regulator was diminished in LNAI cells, consistent with the notion that AKT directly inhibits AFX/Forkhead-mediated transcription of p27(Kip1). To assess directly the impact of increased AKT activity on prostate cancer progression, an activated hAKT1 mutant was overexpressed in LNCaP cells, resulting in a 6-fold increase in xenograft tumor growth. Like LNAI cells, these transfectants showed dramatically reduced p27(Kip1) expression. Together, these data implicate increased AKT activity in prostate tumor progression and androgen independence and suggest that diminished p27(Kip1) expression, which has been repeatedly associated with prostate cancer progression, may be a consequence of increased AKT activity.
Similar articles
-
The progression of LNCaP human prostate cancer cells to androgen independence involves decreased FOXO3a expression and reduced p27KIP1 promoter transactivation.Mol Cancer Res. 2005 Mar;3(3):163-9. doi: 10.1158/1541-7786.MCR-04-0163. Mol Cancer Res. 2005. PMID: 15798096
-
BCR/ABL regulates expression of the cyclin-dependent kinase inhibitor p27Kip1 through the phosphatidylinositol 3-Kinase/AKT pathway.J Biol Chem. 2000 Dec 15;275(50):39223-30. doi: 10.1074/jbc.M007291200. J Biol Chem. 2000. PMID: 11010972
-
PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells.Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15406-11. doi: 10.1073/pnas.95.26.15406. Proc Natl Acad Sci U S A. 1998. PMID: 9860981 Free PMC article.
-
Akt in prostate cancer: possible role in androgen-independence.Curr Drug Metab. 2003 Dec;4(6):487-96. doi: 10.2174/1389200033489226. Curr Drug Metab. 2003. PMID: 14683476 Review.
-
Shepherding AKT and androgen receptor by Ack1 tyrosine kinase.J Cell Physiol. 2010 Aug;224(2):327-33. doi: 10.1002/jcp.22162. J Cell Physiol. 2010. PMID: 20432460 Free PMC article. Review.
Cited by
-
Evidence for PTEN-independent Akt activation and Akt-independent p27(Kip1) expression in advanced bladder cancer.Oncol Lett. 2011 Nov;2(6):1089-1093. doi: 10.3892/ol.2011.374. Epub 2011 Aug 5. Oncol Lett. 2011. PMID: 22848272 Free PMC article.
-
The Use of Soy Isoflavones in the Treatment of Prostate Cancer: A Focus on the Cellular Effects.Nutrients. 2023 Nov 21;15(23):4856. doi: 10.3390/nu15234856. Nutrients. 2023. PMID: 38068715 Free PMC article. Review.
-
Transcription factor KLLN inhibits tumor growth by AR suppression, induces apoptosis by TP53/TP73 stimulation in prostate carcinomas, and correlates with cellular differentiation.J Clin Endocrinol Metab. 2013 Mar;98(3):E586-94. doi: 10.1210/jc.2012-3490. Epub 2013 Feb 5. J Clin Endocrinol Metab. 2013. PMID: 23386643 Free PMC article.
-
_targeting the RAF/MEK/ERK, PI3K/AKT and p53 pathways in hematopoietic drug resistance.Adv Enzyme Regul. 2007;47:64-103. doi: 10.1016/j.advenzreg.2006.12.013. Epub 2007 Mar 26. Adv Enzyme Regul. 2007. PMID: 17382374 Free PMC article. No abstract available.
-
E3 ubiquitin protein ligase, E6-associated protein (E6-AP) regulates PI3K-Akt signaling and prostate cell growth.Biochim Biophys Acta. 2011 Feb;1809(2):119-27. doi: 10.1016/j.bbagrm.2010.08.011. Epub 2010 Sep 6. Biochim Biophys Acta. 2011. PMID: 20826237 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous